Lilly rides Mounjaro, Zepbound to better
Release time：2024-05-22 00:44:40 Source：Stellar Space news portal
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
- Previous：Climber found dead on Denali, North America's tallest peak
- Next：Siblings trying to make US water polo teams for Paris Olympics
Related articles
- Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise
- Woman's death after electric blanket fire triggers warning from Coroner
- Mediaworks data breach: Hackers email victims, demanding $820
- Majority of young New Zealanders want to 'live in a smoke free nation'
- Yvette Fielding says her Most Haunted co
- Weather watches and warnings: What they mean and when they're triggered
- Mediaworks data breach: Hackers email victims, demanding $820
- Moscow attack: Russian court charges four men with act of terrorism
- Ohio judge to rule Monday on whether the state’s abortion ban stands
- Boeing CEO Dave Calhoun to step down in shakeup amid safety crisis
- David Ortiz is humbled by being honored in New York again; this time for post
- 'They cruise, we lose'
- Truancy: Why it matters, what the law says and what is being done about it
- UN mission probing Islamic State crimes forced to shut in Iraq
- China vows to actively promote restoration of int'l flights
- Poppies to be replaced as Dannevirke RSA announces it won't be putting them on graves
- 2 Walk and Cycle Conference: Government's transport approach a 'head wind' to progress
- Fighting rages across Gaza amid revival of truce talks
- Kylie Jenner displays her VERY edgy fashion sense in cleavage
- Tarata Road gravel fix plan raises ire of small Taranaki community
Random recommendation
- Copyright © 2024 Powered by Lilly rides Mounjaro, Zepbound to better ,Stellar Space news portal sitemap